Common antidepressant may help adults with long COVID: study
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
#Canada #Health #Fluvoxamine #longcovid https://globalnews.ca/news/11752953/common-antidepressant-may-help-adults-long-covid/Common antidepressant may help adults with long COVID: study
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
#Canada #Health #Fluvoxamine #longcovid https://globalnews.ca/news/11752953/common-antidepressant-may-help-adults-long-covid/Common antidepressant may help adults with long COVID: study
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
#Canada #Health #Fluvoxamine #longcovid https://globalnews.ca/news/11752953/common-antidepressant-may-help-adults-long-covid/Common antidepressant may help adults with long COVID: study
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
#Canada #Health #Fluvoxamine #longcovid https://globalnews.ca/news/11752953/common-antidepressant-may-help-adults-long-covid/
Hallucinogen DMT an effective antidepressant in small clinical trial
Effectiveness appears to correlate with self-described mystical experience.
Ars Technica
Common Antidepressant Sertraline Found to Lift Mood Within Two Weeks
A new analysis of the PANDA clinical trial reveals that the antidepressant sertraline improves certain emotional symptoms of depression and anxiety within two weeks of starting treatment. A new analysis led by researchers at UCL has found that one of the most widely prescribed antidepressants, se
SciTechDaily